Journals / Haydarpaşa Numune Medical Journal / 2019 / Cilt: 59 - Sayı: 3

The Role and Importance of Antiagregan, Anticoagulant Drugs in the Etiology of Upper Gastrointestinal System Bleeding in Elderly

Pages
250–255
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Gastroprotective drugs should be added to the treatment of patients using these drugs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: In this study, we aimed to determine the role of anticoagulants and antiagregan medications in the etiology and prognosis of the upper gastrointestinal system (GIS) bleeding in elderly patients.
📊
Key Findings & Data:Methods: One hundred and eighty-four patients who were admitted to the emergency department with the complaints of upper GIS bleeding between January and December 2016 were evaluated retrospectively regarding the age, gender, complaints, drugs, endoscopy findings, intensive care requirement and mortality.
💡
Conclusion & Impact:Gastroprotective drugs should be added to the treatment of patients using these drugs.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

Introduction: In this study, we aimed to determine the role of anticoagulants and antiagregan medications in the etiology and prognosis of the upper gastrointestinal system (GIS) bleeding in elderly patients. Methods: One hundred and eighty-four patients who were admitted to the emergency department with the complaints of upper GIS bleeding between January and December 2016 were evaluated retrospectively regarding the age, gender, complaints, drugs, endoscopy findings, intensive care requirement and mortality. Results: The mean age of 184 patients was 78.3±7.9 years. 112 (60.9%) of them were male and 72 (39.1%) of them were female. 128 (69.6%) of the patients applied with only melena, 32(17.4%) with only hematemesis and 24 (13%) were admitted with both hematemesis and melena. Of the patients, 139 (75.9%) were treated in the internal medicine clinic and 31 (16.8%) were treated in the intensive care unit and 12 (6.5%) were expired. The most commonly used drug was acetylsalicylic acid (ASA) (31.5%) and the most common endoscopic finding was peptic ulcer (55.4%). The mean age of the patients treated in the intensive care unit was 81±7.2years, and 18 (58.1%) of those patients were male. The most common endoscopic finding was peptic ulcer- Forrest 2A (16.2%) and ASA (35.5%) was also the most common drug in that group. The mean age of the 12 patients who were expired was 75.3±7.2 years and 8 (66.7%) of them were male. In 12 patients, the most common endoscopic finding was the peptic ulcer and the most frequent drug was warfarin (33%). Discussion and Conclusion: Antiagregan, anticoagulant, NSAI drugs have significant effects on etiology and prognosis of the upper GIS bleeding in the elderly. Gastroprotective drugs should be added to the treatment of patients using these drugs.

🔖

Cite This Article

AKTAŞ, H. Ş. (2019). The Role and Importance of Antiagregan, Anticoagulant Drugs in the Etiology of Upper Gastrointestinal System Bleeding in Elderly. Haydarpaşa Numune Medical Journal, Cilt: 59 - Sayı: 3, 250–255. https://ajindex.com/articles/186269

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population based study. Am J Gastroenterol 1995;90:206–10
  2. Szura M, Pasternak A. Upper non-variceal gastrointestinal bleeding review the effectiviness of endoscopic hemostasis methods. World J Gastrointest Endosc 2015;7:1088–95
  3. Sandel MH, Kolkman JJ, Kuipers EJ, Cuesta MA, Meuwissen SG. Nonvariceal upper gastrointestinal bleeding:differences in outcome for patients admitted to internal medicine and gastroenterological services.Am. J.Gastroenterol 2000;95:2357– 62
  4. Rockall TA,Logan RFA, Devlin HB.Northfield TC.Risk assessment after acute upper gastrointestinal haemorrhage.Gut 1996; 38:316–21
  5. Peter DJ, Dougherty JM. Evaluation of the patient with gastrointestinal bleeding: an evidence based approach. Emerg Med Clin North Am 1999;17:239–61
  6. Palmer K.Acute upper gastrointestinal haemorrhage. Br Med Bull 2007;83:307–24
  7. Solomon DH. NSAIDs: Overview of adverse effects. UpToDate 2009;17:2
  8. McCarthy D. Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: Definition and epidemiology. Am J Med 1998;105:3S–9S
  9. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al; VIGOR Study Group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343:1520–28
  10. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999;340:1888–9
  11. Yalçın MS, Kara B, Öztürk NA, Ölmez Ş, Taşdoğan BE, Taş A. Epidemiology and endoscopic findings of the patients suffering from upper gastrointestinal system bleeding. Dicle Med J 2016;43:73–6
  12. Boonpongmance S, Fleischer DE, Pezzula JC, Collier K, Mayoral W, Al-Kawas F, et al. The frequency of peptic ulcer as a cause of acute upper GI bleeding is exaggerated. Gastrointest Endosc 2004; 59:788–94
  13. Paspatis GA, Matrella E, Kapsoritakis A, Leontithis C, Papanikolaou N, Chlouverakis GJ, et al. An epidemiological study of acute upper gastrointestinal bleeding in Crete, Greece. Eur J Gastroenterol hepatol 2000;12:1215–20
  14. Zaltman C, Souza HS, Castro ME, Sobral Mde F, Dias PC, Lemos V Jr.Upper gastrointestinal bleeding in a Brazilian hospital: a retrospective study of endoscopic records.Arq Gastroenterol 2002;39:74–80
  15. Feldman M, Friedman LS, Sleisenger MH, Gastrointestinal and liver disease: pathophysiology, diagnosis, mana